Eupraxia Pharmaceuticals Inc.

Eupraxia Pharmaceuticals Inc.verified

EPRX

Price:

$5.87

Market Cap:

$207.61M

Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product candidates are EP-104IAR, which is in a Phase III clinical trial for the treatment of unmet medical needs and for pain relief for knee osteoarthritis; EP-104GI, which is in a Phase II clinical trial for the treatment of eosinophilic esophagitis; and EP-104, under preclinical studies for the treatment of other inflammatory joint conditions, benign structures of the esophagus, and epidural delivery. It also is involved in the development of product candidates for oncology. The company was formerly kno...[Read more]

Industry

Biotechnology

IPO Date

Stock Exchange

NASDAQ

Ticker

EPRX

The ROE as of December 2025 (TTM) for Eupraxia Pharmaceuticals Inc. (EPRX) is -118.64%

According to Eupraxia Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current ROE is -118.64%. This represents a change of 222.17% compared to the average of -36.83% of the last 4 quarters.

Eupraxia Pharmaceuticals Inc. (EPRX) Historical ROE (quarterly & annually)

How has EPRX ROE performed in the past?

The mean historical ROE of Eupraxia Pharmaceuticals Inc. over the last ten years is -247.33%. The current -118.64% ROE has changed -52.03% with respect to the historical average. Over the past ten years (40 quarters), EPRX's ROE was at its highest in in the September 2020 quarter at 4.96%. The ROE was at its lowest in in the December 2023 quarter at -184.83%.

Quarterly (TTM)
Annual

Average

-247.33%

Median

-88.41%

Minimum

-1687.19%

Maximum

119.65%

Eupraxia Pharmaceuticals Inc. (EPRX) ROE by Quarter and Year

Discovering the peaks and valleys of Eupraxia Pharmaceuticals Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 832.50%

Maximum Annual ROE = 119.65%

Minimum Annual Increase = -698.36%

Minimum Annual ROE = -1687.19%

Quarterly (TTM)
Annual
YearROEChange
2024-104.59%-93.80%
2023-1687.19%832.50%
2022-180.93%60.45%
2021-112.77%-698.36%
202018.85%-53.54%
201940.57%-66.10%
2018119.65%-265.66%

Eupraxia Pharmaceuticals Inc. (EPRX) Average ROE

How has EPRX ROE performed in the past?

The current ROE of Eupraxia Pharmaceuticals Inc. (EPRX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-657.57%

5-year avg

-413.33%

10-year avg

-247.33%

Eupraxia Pharmaceuticals Inc. (EPRX) ROE vs. Peers

How is EPRX’s ROE compared to its peers?

Eupraxia Pharmaceuticals Inc.’s ROE is greater than MediWound Ltd. (-96.71%), greater than Nautilus Biotechnology, Inc. (-33.35%), less than NEONC TECHNOLOGIES HOLDINGS, INC. (562.99%), greater than Orchestra BioMed Holdings, Inc. (-289.42%), greater than Aardvark Therapeutics, Inc. Common Stock (-54.90%), greater than SELLAS Life Sciences Group, Inc. (-132.51%), less than Inventiva S.A. (536.36%), less than Cartesian Therapeutics, Inc. (286.60%), greater than Genfit S.A. (-63.70%), greater than Protara Therapeutics, Inc. (-36.87%),

Build a custom stock screener for Eupraxia Pharmaceuticals Inc. (EPRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eupraxia Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Eupraxia Pharmaceuticals Inc. (EPRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Eupraxia Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Eupraxia Pharmaceuticals Inc.'s ROE?

How is the ROE calculated for Eupraxia Pharmaceuticals Inc. (EPRX)?

What is the highest ROE for Eupraxia Pharmaceuticals Inc. (EPRX)?

What is the 3-year average ROE for Eupraxia Pharmaceuticals Inc. (EPRX)?

What is the 5-year average ROE for Eupraxia Pharmaceuticals Inc. (EPRX)?

How does the current ROE for Eupraxia Pharmaceuticals Inc. (EPRX) compare to its historical average?